Publicaciones en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (6)

2000

  1. In vitro susceptibility to gemifloxacin and trovafloxacin of Streptococcus pneumoniae strains exhibiting decreased susceptibility to ciprofloxacin

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 19, Núm. 2, pp. 137-139

1997

  1. Pharmacodynamic effects of amoxicillin versus cefotaxime against penicillin-susceptible and penicillin-resistant pneumococcal strains: A phase I study

    Antimicrobial Agents and Chemotherapy, Vol. 41, Núm. 6, pp. 1389-1391

  2. Suspicion of quinolone active metabolite following discrepancy between predicted and experimental urine bactericidal activities

    Antimicrobial Agents and Chemotherapy, Vol. 41, Núm. 5, pp. 927-930

1996

  1. Activities against Streptococcus pneumoniae of amoxicillin and cefotaxime at physiological concentrations: In vitro pharmacodynamic simulation

    Antimicrobial Agents and Chemotherapy, Vol. 40, Núm. 12, pp. 2904-2906

  2. Ex vivo antibacterial properties of rufloxacin compared with those of norfloxacin in a study with healthy volunteers

    Antimicrobial Agents and Chemotherapy, Vol. 40, Núm. 1, pp. 17-21

1994

  1. Immunomodulatory effect of cefminox

    Journal of Antimicrobial Chemotherapy